Drug intelligence / Profile preview

third-generation HPV vaccine

Development stage
Preclinical
Lead developer
Xiamen Innovax Biotech
Modality
Vaccines & Immunotherapeutics
01

Overview

The third-generation HPV vaccine is a **preclinical multivalent chimeric epitope HPV vaccine** being developed by **Xiamen Innovax Biotech** for prevention of **HPV-related diseases**, including **cervical cancer**. The candidate was designed using **structural vaccinology** principles to create a broad-spectrum, \"one-against-multi\" immunogen that incorporates neutralizing epitopes from multiple HPV types into chimeric constructs rather than using separate full virus-like particles for each type. It is produced on Innovax's proprietary **Escherichia coli expression platform** and is intended to elicit neutralizing antibody responses against HPV capsid epitopes with the goal of broad preventive efficacy across HPV-associated disease.

Other names
third-generation HPV vaccinemultivalent chimeric epitope HPV vaccinemulti-valent chimeric epitope HPV vaccine
02

Targets

HPV L1 (Human papillomavirus L1 capsid protein)

Beyond the preview

Go deeper on third-generation HPV vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on third-generation HPV vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call